Evaluating the Outcome of Cardio Selective beta1- Blockers Use in Patients With Copd

• Status: Recruiting
• Trial end date: 2022-01-15
• Target enrollment: 0
• Participant gender: All

Summary

To Evaluate the Outcome of cardio selective beta1 (β1-) blockers use in patients with chronic obstructive pulmonary disease.

Patient education about the COPD and their medications.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Nebivolol

Criteria

Inclusion Criteria:

1. Male or female.

2. informed consent.

3. Age >40years.

4. FEVl/FVC<70%.

5. diagnosed 3 month before enrollment (mild-moderate)

6. Reversability test pre-post bronchodilators FEVl predicted<200ml/hr and less than 12%.

Exclusion Criteria:

1. Asthmatic patient.

2. patient already use B blockers.

3. Acute exacerbation.

4. Pregnency -lactation.

5. Advanced cardiac, renal or liver disease according to investigator opinion.